drugset / Trial / NCT00944463

Trial of Simvastatin and Gemcitabine in Pancreatic Cancer Patients

NCT00944463

Phase 2 Completed 106 enrolled Samsung Medical Center
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to determine whether simvastatin is effective in the treatment of advanced pancreatic cancer patients.

Timeline

Start
2008-10
Primary completion
2013-09
Completion
2014-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Simvastatin Small molecule
Comparator Gemcitabine Small molecule